There are a few shorthand ways to gauge roughly how much FY19's results undersell the potential future earnings power of the software business:
- They sold $22.4m TCV in FY19, but only ($12.1m + $2.4m) = $14.5m was booked through the P&L because $7.9m of the $22.4m TCV sold as subscriptions will be booked in future periods. Hypothetically, if they'd sold $22.4m all in perpetual licenses under the old model, the software division's EBITDA would've nearly doubled (from $8.7m, to $16.6m).
- TARR (maintenance + subscription revenue) at 23rd August was $28.9m, but FY19's P&L booked $24.2m; if you add the delta ($4.7m), EBITDA would've gone from $8.7m to $13.4m.
The $22.4m TCV sold in FY19 is the key, really - it was about 50% higher than their 5-year licence sales average, with the only other year they've come remotely close to that being FY17 when they sold ~$10m to a single customer. If that FY19 TCV of $22.4m represents a "new" baseline post the roll-out of the subscription sales model from which RUL can build, profits and cash flow will improve markedly over the next few years.
- Forums
- ASX - By Stock
- RUL
- Ann: Investor Presentation - 2019 Full Year Review
RUL
rpmglobal holdings limited
Add to My Watchlist
0.34%
!
$2.91

Ann: Investor Presentation - 2019 Full Year Review, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.91 |
Change
-0.010(0.34%) |
Mkt cap ! $642.2M |
Open | High | Low | Value | Volume |
$2.94 | $2.95 | $2.88 | $439.2K | 150.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1254 | $2.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.91 | 310 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10995 | 2.860 |
2 | 7900 | 2.850 |
2 | 18649 | 2.840 |
2 | 2450 | 2.830 |
1 | 4000 | 2.810 |
Price($) | Vol. | No. |
---|---|---|
2.950 | 12740 | 2 |
2.980 | 30000 | 2 |
3.000 | 10000 | 1 |
3.040 | 987 | 1 |
3.060 | 5000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RUL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online